Clopidogrel and endothelial injury after percutaneous coronary interventions: beyond the antiplatelet effects.
Rudez
Goran
G
Duckers
Hendricus J
HJ
Simoons
Maarten L
ML
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D001792:Blood Platelets / Q000187:drug effects; D000077144:Clopidogrel; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000293:injuries; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D019919:Prosthesis Implantation / Q000009:adverse effects; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D015607:Stents / Q000009:adverse effects; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014652:Vascular Diseases / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control
C548576:P2RY12 protein, human; D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D000077144:Clopidogrel; D013988:Ticlopidine